Biomagnetik Park Holding GmbH

Biomagnetik Park Holding GmbH is a German technology company that develops quantum sensing platforms for non-invasive cardiology diagnostics and precision medicine based on magnetocardiography (MCG). The headquarters are located in Germany.

Here are key aspects of the company:

• Innovation: The company utilizes highly sensitive quantum sensors to measure intra-cellular ion currents deep within heart tissue, achieving signal sensitivity in the single-digit femto-Tesla range without attenuation by bone or tissue.
• Products & Services: Their solution includes an advanced physical platform based on quantum sensing, software platforms for clinical research and diagnostics, certified scores for major heart diseases, and assays for cardiac precision medicine scheduled for delivery starting in 2027.
• Industries: The firm focuses on cardiology, precision medicine, drug development, and the medical technology sector to revolutionize diagnostic accuracy and patient-specific medication strategies.

Biomagnetik Park Holding GmbH leverages over two decades of research into non-invasive magnetic field measurements to create a semi-open platform that enables physicians to derive cardiac action potentials without invasive procedures like biopsies or punctures.